Literature DB >> 14709771

The role of CSF-1 in normal physiology of mammary gland and breast cancer: an update.

Eva Sapi1.   

Abstract

Colony stimulating factor (CSF-1) and its receptor (CSF-1R, product of c-fms proto-oncogene) were initially implicated as essential for normal monocyte development as well as for trophoblastic implantation. However, studies have demonstrated that CSF-1 and CSF-1R have additional roles in mammary gland development during pregnancy and lactation. This apparent role for CSF-1/CSF-1R in normal mammary gland development is very intriguing because this receptor/ligand pair has also been found to be important in the biology of breast cancer in which abnormal expression of CSF-1 and its receptor correlates with tumor cell invasiveness and adverse clinical prognosis. Recent findings also implicate tumor-produced CSF-1 in promotion of bone metastasis in breast cancer, and a certain membrane-associated form of CSF-1 appears to induce immunity against tumors. This review aims to summarize recent findings on the role of CSF-1 and its receptor in normal and neoplastic mammary development that may elucidate potential relationships of growth factor-induced biological changes in the breast during pregnancy and tumor progression.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14709771     DOI: 10.1177/153537020422900101

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN: 1535-3699


  34 in total

1.  Toll-like receptors stimulate regulated intramembrane proteolysis of the CSF-1 receptor through Erk activation.

Authors:  Gary Glenn; Peter van der Geer
Journal:  FEBS Lett       Date:  2008-02-21       Impact factor: 4.124

2.  IL-12 could induce monocytic tumor cells directional differentiation.

Authors:  Ting-Ting Ma; Bi-Tao Wu; Yan Lin; Hai-Yu Xiong; Qin Wang; Zi-Wei Li; Feng Cheng; Zhi-Guang Tu
Journal:  Mol Cell Biochem       Date:  2015-01-07       Impact factor: 3.396

Review 3.  Extracellular assembly and activation principles of oncogenic class III receptor tyrosine kinases.

Authors:  Kenneth Verstraete; Savvas N Savvides
Journal:  Nat Rev Cancer       Date:  2012-10-18       Impact factor: 60.716

Review 4.  Cytokine networks that mediate epithelial cell-macrophage crosstalk in the mammary gland: implications for development and cancer.

Authors:  Xuan Sun; Wendy V Ingman
Journal:  J Mammary Gland Biol Neoplasia       Date:  2014-06-13       Impact factor: 2.673

Review 5.  Stromal fibroblasts and the immune microenvironment: partners in mammary gland biology and pathology?

Authors:  Ashleigh Unsworth; Robin Anderson; Kara Britt
Journal:  J Mammary Gland Biol Neoplasia       Date:  2014-07-02       Impact factor: 2.673

6.  Inhibition of colony-stimulating-factor-1 signaling in vivo with the orally bioavailable cFMS kinase inhibitor GW2580.

Authors:  James G Conway; Brad McDonald; Janet Parham; Barry Keith; David W Rusnak; Eva Shaw; Marilyn Jansen; Peiyuan Lin; Alan Payne; Renae M Crosby; Jennifer H Johnson; Lloyd Frick; Min-Hwa Jasmine Lin; Scott Depee; Sarva Tadepalli; Bart Votta; Ian James; Karen Fuller; Timothy J Chambers; Frederick C Kull; Stanley D Chamberlain; Jeff T Hutchins
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-25       Impact factor: 11.205

Review 7.  Role of CSF-1 in progression of epithelial ovarian cancer.

Authors:  Setsuko K Chambers
Journal:  Future Oncol       Date:  2009-11       Impact factor: 3.404

8.  The macrophage colony-stimulating factor 1 response signature in breast carcinoma.

Authors:  Andrew H Beck; Inigo Espinosa; Badreddin Edris; Rui Li; Kelli Montgomery; Shirley Zhu; Sushama Varma; Robert J Marinelli; Matt van de Rijn; Robert B West
Journal:  Clin Cancer Res       Date:  2009-02-01       Impact factor: 12.531

9.  Profiling Y561-dependent and -independent substrates of CSF-1R in epithelial cells.

Authors:  Melodie L Knowlton; Laura M Selfors; Carolyn N Wrobel; Ting-Lei Gu; Bryan A Ballif; Steven P Gygi; Roberto Polakiewicz; Joan S Brugge
Journal:  PLoS One       Date:  2010-10-26       Impact factor: 3.240

10.  Raising gestational choline intake alters gene expression in DMBA-evoked mammary tumors and prolongs survival.

Authors:  Vesela P Kovacheva; Jessica M Davison; Tiffany J Mellott; Adrianne E Rogers; Shi Yang; Michael J O'Brien; Jan Krzysztof Blusztajn
Journal:  FASEB J       Date:  2008-12-01       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.